The Medicinal Chemistry team focuses on the optimization of compounds which are identified as effective against target diseases through primary screening.
The areas of activity include:
- Advancing and accelerating the optimization on drug discovery program
- Developing novel chemical platform technology for innovative drug discovery (Establishment of PROTAC platform)
- Developing probe molecules for identifying target and understanding the in vivo mechanism of drug candidates
- Developing tool compounds for monitoring drug localization in either the cell or living animal
- Provide open analytical chemistry services, synthesis know-hows and molecular modeling analysis by giving access to IPK’s well-equipped infrastructure to support academia and pharmaceutical companies.